|7. || |
Confidential Information. Danforth acknowledges and agrees that during the course of performing the Services, Danforth may receive, come into possession of or otherwise become aware of technical, scientific and non-technical and non-scientific information relating to the Company and its business, including, without limitation information relating to the Companys strategy, products and technologies and any derivatives, improvements and enhancements related to any of the foregoing or to the Companys suppliers or business partners (collectively, Confidential Information) whether in graphic, written, electronic or oral form. Confidential Information may be labeled or identified at the time of disclosure as confidential or proprietary, or equivalent, but Confidential Information also includes information which by its context would reasonably be deemed to be confidential and proprietary. Confidential Information also includes, without limitation, unpublished patent applications and other intellectual property filings, ideas, work product, techniques, works of authorship, models, inventions, compounds, compositions, know-how, processes, algorithms, formulae, information and trade secrets as well as financial information (including sales forecasts, profits, pricing methods and models), research data, clinical data, prospect and supplier lists, investors, employees, business and contractual relationships (including with third parties), and business and marketing plans and any derivatives, improvements and enhancements related to any of the above. Information the Company provides to Danforth or Danforth otherwise acquires regarding third parties as to which the Company has an obligation of confidentiality also constitutes Confidential Information.